Super investor and a Warren Buffett of India, Mukul Agarwal, has just added two new stocks to his portfolio sending the ...

In November 2025, KOMZIFTI was added to the National Comprehensive Cancer Network ® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) as a Category 2A recommended treatment option ...

Deliver on 2026 OJEMDA net product revenue guidance, with a focus on increasing persistency and driving new patient starts to support continued OJEMDA adoption as standard of care (SOC) in 2L ...